Traws Pharma Inc.

NASDAQ: TRAW · Real-Time Price · USD
1.48
-0.14 (-8.64%)
At close: Aug 15, 2025, 12:54 PM

Traws Pharma Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-166.52M -18.95M -18.96M -16.16M
Depreciation & Amortization
12K 16K 14K 14K
Stock-Based Compensation
1.39M 1.3M 1.17M 576K
Other Working Capital
-5.47M -2.07M 381K -1.52M
Other Non-Cash Items
141.9M -437K 98K -321K
Deferred Income Tax
n/a 437K -98K n/a
Change in Working Capital
-6.57M -301K 1.48M -3.59M
Operating Cash Flow
-29.79M -17.93M -16.29M -19.49M
Capital Expenditures
n/a -14K n/a n/a
Cash Acquisitions
-3.65M n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-3.65M -14K n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 519K
Financial Cash Flow
33.98M n/a n/a 55.56M
Net Cash Flow
517K -17.94M -16.31M 36.05M
Free Cash Flow
-29.79M -17.95M -16.29M -19.49M